HHS and 19 other government agencies can follow through with firing thousands of probationary workers after a federal appeals ...

It’s a biotech environment without many good choices. Even before President Donald Trump’s tariff announcement pushed stock ...

FDA removes safety program requirement for Idorsia's blood pressure drug Tryvio, Solu gets $41M Series A with Eli Lilly backing, Vincerx shutters, Cytora reports stem cell win in ulcers ...

Executives of major pharmaceutical companies warned the European Union that they’re likely to take the US’ side amid the ...

The nonprofit drug pricing watchdog Institute for Clinical and Economic Review on Wednesday released a new report outlining ...

Novo Nordisk focused on a unique argument in federal appeals court on Tuesday in a case that will consider the extent to ...

A congressional commission is calling for at least a $15 billion federal investment in America’s biotechnology sector, ...

FDA staff cuts could trigger user fee clawback mechanism, but experts including Patrick Frey and David Risinger say immediate ...

Cartesian Therapeutics reports sustained benefits of Descartes-08 CAR-T therapy in generalized myasthenia gravis patients, ...

The state of the US biosimilar market isn't as healthy as it should be despite significant advances in the past decade, ...

The Trump administration on Tuesday said it will challenge a federal judge’s order that blocks its planned 15% rate limit on ...

To make sense of the stock selloff that started late last week, Endpoints News’ Max Bayer and Drew Armstrong spoke to Leerink ...